logo

Shariah compliance overview

Not Halal

Spero Therapeutics, Inc. (SPRO) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Spero Therapeutics, Inc.

Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States.

Spero Therapeutics, Inc. (SPRO) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Interest-bearing securities and assets.

Business Activity
4.04%Limit 5%Pass
Interest-bearing debt
2.07%Limit 30%Pass
Interest-bearing securities and assets
42.55%Limit 30%Fail
Dividend purification
4.04%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Spero Therapeutics, Inc. (SPRO). Current Akinda screening label: Not Halal.